Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/targeting-biofilms-in-translational-research-device-development-and-industrial-sectors/descriptif_4260453
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4260453

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors, 1st ed. 2019

Langue : Anglais

Coordonnateur : Williams Dustin L.

Couverture de l’ouvrage Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors
This book offers a much-needed discussion on the targeting of biofilm-related infections. Chapters include discussions on the impact of biofilm on medical implants, industrial applications, as well as wound and tissue infections. It also offers discussions on regulatory management for industrial sectors and medical environments. Given that there continues to be a paucity of effective antimicrobial products, devices, and coatings in clinical and industrial use that effectively reduce rates of infection or biofilm-related problems, Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors, offers a fresh and much-needed perspective aimed at helping create healthier controlled environments and safer devices.  

This comprehensive book is indispensable for industrial and academic translational researchers, device developers, and regulatory experts looking to create more effective antimicrobial products. 
​Overview and data in biofilm sectors: why targeting biofilms is necessary, Dustin Williams

Impact of biofilms in orthopaedics as they relate to regulatory requirements and needs to be met, David Armbruster, MS, MSE, R&D Group Manager, DePuy Synthes

Clinical problems of biofilm implant-related infection and methods/need to target biofilms in patients, Javad Parvizi, MD, Professor of Orthopaedic Surgery, Rothman Institute at Thomas Jefferson University Hospital

Impact of biofilms in catheter systems and regulatory considerations,

Bryan Haymond, MBA, Product Manager, Bard Access Systems

Potential benefits of targeting biofilms in wound-related and other tissue infections, Garth James, PhD, Associate Research Professor, Center for Biofilm Engineering, Montana State University

Biofilms, prevalence and problems related to injured sold
iers and military healthcare facilities, COL Clinton K. Murray, MD, FACP, FIDSA, Colonel, US Army

FDA insight into the biofilm problem and regulatory management strategy for medical devices, K. Scott Phillips, PhD, Biofilms Research Group Leader, The US FDA and CDR US Public Health Service

Benefits of standardizing approaches to assessing antimicrobial efficacies against biofilms for industrial applications, Darla Goeres, PhD, Associate Research Professor, Chemical & Biological Engineering, Standards Biofilm Methods Laboratory, Center for Biofilm Engineering, Montana State University

EPA insight in the biofilm problem and regulatory management strategy for industrial sectors, Steve Tomasino, PhD, Senior Scientist, Environmental Protection Agency
Dustin L. Williams has developed translational animal models of biofilm-related infection to mimic clinical scenarios, such as open fractures, wherein biofilms from natural sources (e.g. soil) may be initial contaminants of a wound site. He is a founding member of three companies that have been launched out of the University of Utah; each focusing on anti-biofilm technologies. In 2016, he became the Director of the Bone and Joint Research Lab located in the Department of Veterans Affairs in Salt Lake City, UT. Dustin and his team manage research programs that span biofilm-related infections, osseointegration, bone pathologies such as heterotopic ossification, and specialize in hard plastic embedment for histological analysis.

 

Outlines the benefits of targeting biofilm-related infections

Provides discussion on creating more effective antimicrobial coatings for medical implants

Offers perspective on regulatory management for clinical and industrial environments

Date de parution :

Ouvrage de 162 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 158,24 €

Ajouter au panier

Date de parution :

Ouvrage de 162 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 158,24 €

Ajouter au panier